US Seeks To Expand Monkeypox Testing As Narrative Keeps On Rolling By Tyler Durden for Zero Hedge
The Biden administration is working to expand monkeypox testing capabilities beyond a narrow group of public health labs, as infectious disease experts are now suggesting that testing for the virus needs to become part of routine care.
As the Epoch Times notes, Centers for Disease Control and Prevention (CDC) Director Dr. Rochelle Walensky said during a conference call on Friday that her agency is working with the Food and Drug Administration (FDA) and Centers for Medicare and Medicaid Services (CMS) to expand testing capacity to include commercial laboratories.
At present, monkeypox testing is done through a network of 69 public health laboratories, which send results to the CDC for confirmation.
Support Our Site
Now is your chance to support Gospel News Network.
We love helping others and believe that’s one of the reasons we are chosen as Ambassadors of the Kingdom, to serve God’s children. We look to the Greatest Commandment as our Powering force.
So far, there have been 50 confirmed cases in the US across 16 states, while roughly 300 monkeypox tests have been administered.
“There is not enough testing going on now for monkeypox in the United States,” said Dr. Tom Inglesby, director of the Johns Hopkins Center for Health Security. “The commercial labs are used to working with healthcare providers from across the country, moving samples around quickly, reporting results quickly in a way that providers understand and expect.”
Meanwhile, as Off-Guardian notes, monkeypox hysteria continues – with The Atlantic publishing a recent piece suggesting that monkeypox “Could be nothing,” or “Could Be the Next Syphilis.”
Nature asks, “can the global outbreaks be contained?”
That said, there has been some pushback to the ‘dire’ sounding headlines – with the CDC declaring that it was “very unlikely” monkeypox is airborne (in response to a NYT article claiming it can become so), and the Washington Post noting that “Number of monkeypox cases grows, but U.S. officials say overall risk is low.”
And despite monkeypox’s relatively low transmission rate, as we noted on Sunday, the Biden administration has ordered 500,000 more doses of monkeypox vaccine.
Denmark-based biotech group Bavarian Nordic, the manufacturer of the vaccines, said that the U.S. Biomedical Advanced Research and Development Authority (BARDA) has placed the order, to be delivered later this year.
